Cargando…
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-last...
Autores principales: | Sun, Shiyu, Cai, Yueqi, Song, Tian-Zhang, Pu, Yang, Cheng, Lin, Xu, Hairong, Sun, Jing, Meng, Chaoyang, Lin, Yifan, Huang, Haibin, Zhao, Fang, Zhang, Silin, Gao, Yu, Han, Jian-Bao, Feng, Xiao-Li, Yu, Dan-Dan, Zhu, Yalan, Gao, Pu, Tang, Haidong, Zhao, Jincun, Zhang, Zheng, Yang, Jiaming, Hu, Zhenxiang, Fu, Yang-Xin, Zheng, Yong-Tang, Peng, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280646/ https://www.ncbi.nlm.nih.gov/pubmed/34267349 http://dx.doi.org/10.1038/s41422-021-00531-8 |
Ejemplares similares
-
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021) -
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
por: Lin, Yifan, et al.
Publicado: (2022) -
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020) -
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
por: Liang, Qingtai, et al.
Publicado: (2022) -
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
por: Li, Yulei, et al.
Publicado: (2023)